Partnership is Key to Developing Medicines for the World’s Poor

01.09.17

An estimated two billion people lack the medicines they need. The 2016 Access to Medicines Index analyzes pharmaceutical companies’ efforts to improve access to medicines, vaccines and diagnostics for low- and middle-income countries.

Read more

Neglected Tropical Diseases: 21st Century Ancient Afflictions of the Poor and Vulnerable

11.10.16

Sabin Vaccine Institute President Dr. Peter Hotez gave the keynote address on NTDs at the Pontifical Council for Health Care Workers’ XXXI International Conference, focused on NTDs and rare diseases.

Read more

World Health Day 2014: Drawing Attention to Vector-Borne Diseases

04.03.14

More than half of the world’s population is at risk of contracting diseases carried by small organisms like mosquitoes, snails and sand flies.

Read more

Indonesia’s Competitiveness at risk from Neglected Diseases of Poverty

Sabin's picture Submitted by Sabin on

WASHINGTON, D.C. – February 27, 2014 – The control and elimination of neglected tropical diseases (NTDs) is one of the most cost-effective ways Indonesia can sustain economic growth and reduce inequality, said scientists today in an analysis published in PLOS Neglected Tropical Diseases. While Indonesia is poised to defeat NTDs by 2020, it has an opportunity to scale up national programs, integrate NTDs with other development efforts, strengthen coordination and enhance collaboration among key partners.

Gates, pharma and other partners commit to accelerated R&D to find new treatments for NTDs

02.02.12
Earlier this week 13 pharmaceutical companies*, together with several government and nongovernmental organizations**, pledged to find solutions to eliminate or control 10 neglected tropical diseases (NTDs) by the year 2020. At an event in London, pharmaceutical companies committed to invest in research and development (R&D) to find new treatments for NTDs along with increasing donations of existing drugs.
Read more